Do you give SRS/fSRS or would you ever elect to closely observe if the patient is receiving immunotherapy/targeted agents?
I find postop that these large cavities have high risk of radiation necrosis and I'm afraid 30Gy/5 fx is not enough to control melanoma cells anyway so tend to feel we should observe these and treat at recurrence but wondering if anyone has similar experience or data to support this? It seems to me that RN is a big issue requiring steroids that will counteract any IO therapy?